Transforming the Pharmaceutical Supply Chain - by Hedley Rees (Hardcover)

From the Back Cover

Effective and insightful solutions to the most pressing supply chain challenges facing pharmaceutical companies today

In Transforming the Pharmaceutical Supply Chain, veteran biotech supply chain strategist, Hedley Rees, delivers a reasoned and systematic solution to the most widespread and relevant challenges in the pharmaceutical supply chain. The book explains the deeply rooted issues within pharma supply chains and the modus operandi of the industry while also discussing effective solutions to the underlying causes that led to widespread system breakdown.

The author applies modern methods of product development and commercial supply successfully used by leaders in the field. He provides real-world examples of ways to make the delivery of medicines to patients efficient and effective.

Readers will also find:

• A clear explanation of the development, manufacture, and delivery of drugs to patients
• Comprehensive explorations of the issues and challenges to the current supply chain system paired with effective solutions
• Expert witness accounts, anecdotes, case studies and examples of pharmaceutical supply chain difficulties and solutions
• Complete treatments of how to adapt supply chain techniques to a pharmaceutical era dominated by biologics and advanced therapies

Perfect for pharmaceutical and biopharmaceutical professionals working in drug development, Transforming the Pharmaceutical Supply Chain will also benefit industry professionals with a responsibility for the logistics, commercial supply, manufacturing, regulation, quality management, finance, and marketing of pharmaceuticals.

About the Author

Hedley Rees, PhD, is Managing Consultant at PharmaFlow Ltd. He has 25 years' experience in the biotech industry, advising drug developers in the strategic management of their preclinical, clinical, and commercial supply chains. He is the author of Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics.